Bayer (BAYN GY) to make a USD 10.5bln push to settle roundup cases, according to Bloomberg

Bayer's decision to allocate $10.5 billion to settle Roundup litigation cases is significant, as it reflects their strategy to mitigate ongoing legal risks and potentially stabilize investor sentiment.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

SoftBank (9984 JT) dissolves its share stake in NVIDIA (NVDA), according to a SEC filing

UK DMO to sell GBP 3bln of 4.125% Treasury Gilt in 2033 on the 24th of February, via auction

Bayer (BAYN GY) to make a USD 10.5bln push to settle roundup cases, according to Bloomberg

US FDA accepts Bristol Myers Squibb's (BMY) new drug application for Iberdomide in patients with relapsed or refractory multiple Myeloma; target action date of August 17th

US President Trump to visit Georgia state to spotlight economy and affordability

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This sizeable financial commitment could weigh on their near-term earnings but may improve their long-term outlook by removing a considerable uncertainty. Investors should monitor how this settlement may influence Bayer's stock performance and its implications for the broader pharmaceuticals sector.

Related headlines

The whole workspace, free to try.

Try it free